apologize for giving the wrong Rojkind reference. For historical interest, we used the 1976 (3) publication, but by error, referred to the 1979 one ( 1). Dr. W. J. Lindblad makes an excellent point. The methods section was markedly abbreviated and the paper, as published, does give the misleading i
Thymostimulin treatment in acute type B-viral hepatitis
β Scribed by S. Corridori
- Publisher
- Elsevier Science
- Year
- 1985
- Tongue
- English
- Weight
- 77 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0192-0561
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Tong et al. recently described the failure of several hepatitis B virus (HBV) treatment guidelines to identify treatment eligibility for a significant proportion of 67 of their patients who went on to develop hepatocellular carcinoma or died of liver-related complications, probably due to disease pr
## Abstract We report a patient with antibody to hepatitis B surface antigen (antiβHBs) but no antibodies to other hepatitis B virus components, who developed acute symptomatic type B hepatitis. The possible explanations for this unusual serological pattern are 1) the antibodyβpositive status, whic
The aetiology of acute hepatitis in Taiwan: acute hepatitis superimposed on HBsAg carrier state as the main aetiology of acute hepatitis in areas with high HBsAg carrier rate. Infection 1988;
Elevated neopterin levels in blood or urine have been shown to be a marker for the activation of cell-mediated immunity in vitro and in vivo. To evaluate whether neopterin levels are elevated in patients with acute viral hepatitis, we measured urinary levels in 13 patients with hepatitis A, 26 with